FDA Inspection 1287536 — S&B Pharma LLC d.b.a. Norac Pharma
The FDA completed an inspection of S&B Pharma LLC d.b.a. Norac Pharma on September 19, 2025 in Azusa, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 19, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Azusa, CA (United States)